Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-19-018899
Date:2019-09-27
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
Original Submission Date:

Reporting Person:

BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST. SAN RAFAEL, CA 94901

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-09-27 M 1,000 a $21.51 327,520 direct
COMMON STOCK 2019-09-27 0 $0.00 181,341 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 21.51 2019-09-27 deemed execution date M 1,000 (d) 2010-11-12 2020-05-11 common stock 1,000 $21.51 138,000 direct
Footnotes
IDfootnote
f1 reflects the number of options outstanding after the transactions from this specific stock option grant.
WhaleWisdom Logo

Elevate your investments